Avidity Partners Management as of March 31, 2021
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 94 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbvie (ABBV) | 6.2 | $225M | 2.1M | 108.22 | |
| Astrazeneca Sponsored Adr (AZN) | 5.0 | $182M | 3.7M | 49.72 | |
| Avantor (AVTR) | 4.0 | $144M | 5.0M | 28.93 | |
| Medtronic SHS (MDT) | 3.3 | $121M | 1.0M | 118.13 | |
| Arvinas Ord (ARVN) | 3.2 | $116M | 1.8M | 66.10 | |
| Intuitive Surgical Com New (ISRG) | 2.8 | $103M | 139k | 738.94 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 2.7 | $98M | 2.8M | 35.64 | |
| Cardinal Health (CAH) | 2.5 | $89M | 1.5M | 60.75 | |
| Syndax Pharmaceuticals (SNDX) | 2.4 | $86M | 3.8M | 22.36 | |
| Essa Pharma Com New (EPIX) | 2.3 | $83M | 2.8M | 29.05 | |
| Mirati Therapeutics | 2.3 | $82M | 476k | 171.30 | |
| Seagen | 2.2 | $80M | 578k | 138.86 | |
| EXACT Sciences Corporation (EXAS) | 2.2 | $79M | 598k | 131.78 | |
| Nuvation Bio Com Cl A (NUVB) | 2.2 | $79M | 7.5M | 10.45 | |
| Biohaven Pharmaceutical Holding | 2.0 | $72M | 1.0M | 68.35 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.8 | $67M | 311k | 214.89 | |
| I Mab Sponsored Ads (IMAB) | 1.8 | $64M | 1.3M | 48.47 | |
| Arena Pharmaceuticals Com New | 1.7 | $62M | 899k | 69.39 | |
| Alnylam Pharmaceuticals (ALNY) | 1.7 | $60M | 428k | 141.19 | |
| Bausch Health Companies (BHC) | 1.7 | $60M | 1.9M | 31.74 | |
| Catalent (CTLT) | 1.6 | $59M | 560k | 105.31 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.5 | $55M | 1.3M | 43.39 | |
| Horizon Therapeutics Pub L SHS | 1.5 | $54M | 581k | 92.04 | |
| Blueprint Medicines (BPMC) | 1.5 | $53M | 546k | 97.23 | |
| Zimmer Holdings (ZBH) | 1.4 | $52M | 326k | 160.08 | |
| Neurocrine Biosciences (NBIX) | 1.4 | $51M | 521k | 97.25 | |
| Bridgebio Pharma (BBIO) | 1.4 | $50M | 815k | 61.60 | |
| Chemocentryx | 1.3 | $48M | 941k | 51.24 | |
| Acceleron Pharma | 1.2 | $44M | 323k | 135.61 | |
| Trillium Therapeutics Com New | 1.2 | $43M | 4.0M | 10.74 | |
| Abiomed | 1.2 | $42M | 133k | 318.73 | |
| Natera (NTRA) | 1.1 | $40M | 396k | 101.54 | |
| Shattuck Labs (STTK) | 1.1 | $39M | 1.3M | 29.24 | |
| Inovio Pharmaceuticals Com New | 1.0 | $37M | 4.0M | 9.28 | |
| Kadmon Hldgs | 1.0 | $37M | 9.5M | 3.89 | |
| Alphatec Hldgs Com New (ATEC) | 1.0 | $37M | 2.3M | 15.79 | |
| Biohaven Pharmactl Hldg Co L call Call Option | 1.0 | $36M | 523k | 68.35 | |
| Ideaya Biosciences (IDYA) | 1.0 | $35M | 1.5M | 23.50 | |
| Dynavax Technologies Corp Com New (DVAX) | 1.0 | $34M | 3.5M | 9.83 | |
| Cigna Corp (CI) | 0.9 | $33M | 135k | 241.74 | |
| Orchard Therapeutics Ads | 0.9 | $31M | 4.3M | 7.26 | |
| Athira Pharma (ATHA) | 0.9 | $31M | 1.7M | 18.40 | |
| Aldeyra Therapeutics (ALDX) | 0.8 | $30M | 2.6M | 11.88 | |
| Cullinan Oncology (CGEM) | 0.8 | $30M | 707k | 41.67 | |
| Harpoon Therapeutics | 0.8 | $30M | 1.4M | 20.92 | |
| Adicet Bio (ACET) | 0.8 | $29M | 2.2M | 13.08 | |
| Sotera Health (SHC) | 0.8 | $29M | 1.2M | 24.96 | |
| Organogenesis Hldgs (ORGO) | 0.7 | $27M | 1.5M | 18.22 | |
| Bellus Health Com New | 0.7 | $26M | 6.8M | 3.84 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.7 | $25M | 1.3M | 18.51 | |
| Sana Biotechnology (SANA) | 0.7 | $25M | 732k | 33.47 | |
| Immunocore Hldgs Ads (IMCR) | 0.6 | $23M | 550k | 42.57 | |
| Curis Com New | 0.6 | $23M | 2.1M | 11.32 | |
| Aurinia Pharmaceuticals (AUPH) | 0.6 | $23M | 1.8M | 12.98 | |
| Cardiff Oncology (CRDF) | 0.6 | $23M | 2.4M | 9.26 | |
| Igm Biosciences (IGMS) | 0.6 | $23M | 293k | 76.69 | |
| Bolt Biotherapeutics (BOLT) | 0.6 | $22M | 654k | 32.91 | |
| Chimerix (CMRX) | 0.6 | $22M | 2.2M | 9.64 | |
| Gritstone Oncology Ord (GRTS) | 0.6 | $20M | 2.1M | 9.43 | |
| Bioventus Com Cl A (BVS) | 0.5 | $19M | 1.3M | 15.28 | |
| Sigilon Therapeutics | 0.5 | $19M | 851k | 22.35 | |
| Si-bone (SIBN) | 0.5 | $18M | 578k | 31.81 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.5 | $18M | 740k | 23.70 | |
| Oncosec Medical Incorporated | 0.5 | $17M | 3.5M | 4.77 | |
| Alpine Immune Sciences (ALPN) | 0.4 | $16M | 1.5M | 10.60 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.4 | $15M | 4.3M | 3.46 | |
| Kezar Life Sciences (KZR) | 0.3 | $11M | 1.9M | 5.96 | |
| Pharvaris N V (PHVS) | 0.3 | $11M | 400k | 27.98 | |
| Adamas Pharmaceuticals | 0.3 | $11M | 2.2M | 4.80 | |
| Affimed Therapeutics B V | 0.3 | $10M | 1.3M | 7.91 | |
| Merus N V (MRUS) | 0.3 | $10M | 487k | 20.89 | |
| Scynexis Com New (SCYX) | 0.3 | $10M | 1.3M | 7.94 | |
| Instil Bio | 0.3 | $10M | 400k | 25.08 | |
| Immatics SHS (IMTX) | 0.3 | $9.9M | 885k | 11.21 | |
| Terns Pharmaceuticals (TERN) | 0.2 | $8.8M | 400k | 22.00 | |
| Evelo Biosciences | 0.2 | $8.6M | 800k | 10.70 | |
| Cm Life Sciences Com Cl A | 0.2 | $8.2M | 550k | 14.89 | |
| Vesper Healthcare Acqstn Cor Unit 99/99/9999 | 0.2 | $6.9M | 600k | 11.55 | |
| Arya Sciences Acquisition Com Cl A | 0.2 | $6.9M | 500k | 13.78 | |
| Argenx Se Sponsored Adr (ARGX) | 0.2 | $5.5M | 20k | 275.40 | |
| Bcls Acquisition Corp Com Cl A | 0.1 | $5.3M | 500k | 10.57 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $5.2M | 500k | 10.47 | |
| Medicus Sciences Acquisition Unit 99/99/9999 | 0.1 | $5.1M | 520k | 9.85 | |
| Healthcor Catalio Acqu Corp Cl A Shs | 0.1 | $5.0M | 500k | 10.00 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $4.5M | 400k | 11.19 | |
| Cm Life Sciences Ii Unit 02/25/2028 | 0.1 | $4.3M | 337k | 12.80 | |
| Helix Acquisition Corp Com Cl A | 0.1 | $4.1M | 400k | 10.20 | |
| Lifesci Acquisition Ii Corp | 0.1 | $4.1M | 400k | 10.14 | |
| Cogent Biosciences (COGT) | 0.1 | $3.7M | 418k | 8.78 | |
| Bctg Acquisition Corp | 0.1 | $3.3M | 300k | 11.12 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.1 | $2.4M | 233k | 10.16 | |
| Annexon (ANNX) | 0.1 | $1.9M | 70k | 27.84 | |
| American Well Corp Cl A (AMWL) | 0.0 | $1.2M | 70k | 17.37 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $267k | 100k | 2.67 |
